Artiva Biotherapeutics, Inc.ARTVEarnings & Financial Report

Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)

Deep AnalysisCompare

Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing off-the-shelf natural killer (NK) cell therapies for the treatment of cancers and autoimmune diseases. Its product pipeline covers both hematologic malignancies and solid tumors, and it operates primarily in the global biopharmaceutical sector, advancing accessible, high-efficacy immunotherapies to address unmet patient medical needs.